Brief: Hemostemix Receives Health Canada Clearance To Continue With Critical Limb Ischemia Clinical Trials
20/12/2017 12:30
Dec 20 (Reuters) - Hemostemix Inc HEM.V :
* HEMOSTEMIX RECEIVES HEALTH CANADA CLEARANCE TO CONTINUE
WITH
CRITICAL LIMB ISCHEMIA CLINICAL TRIALS
* HEMOSTEMIX INC - RECEIVED NO OBJECTION LETTER FROM HEALTH
CANADA
FOR CURRENT CLINICAL TRIAL OF ACP-01 FOR PATIENTS WITH CRITICAL
LIMB ISCHEMIA
* HEMOSTEMIX INC - EXPECTS CLINICAL TRIALS IN UNITED STATES
TO
RECEIVE CLEARANCE IN EARLY 2018
Source text for Eikon: ID:nGNXOKCNRa
Further company coverage: HEM.V
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Hemostemix
See all newsBrief: Hemostemix Announces Financing Update And Secured Convertible Debenture Financing Of Up To $2,000,000
Brief: Aspire Health Science Files Supplemental Motion For Expedited Hearing In Lawsuit Against Hemostemix Inc. And Suspends Patient Recruitment For Hemostemix Cli Phase 2 Clinical Trial
Brief: Aspire Health Sciences Says On Jan 28, 2020, Initiated Legal Proceeding Against Hemostemix Inc
Brief: Hemostemix Announces Private Placement
Brief: Hemostemix Announces Corporate Update